In a recent series of papers, LeRoith and colleagues utilized a mouse model of genetically induced insulin resistance that develops hyperinsulinemia without obesity to examine how insulin signaling impacts mammary tumor growth in vivo. This evidence concerns the gene INS and Obesity.